Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Sep 29, 2021
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how using sunscreen may affect the appearance of scars after surgery on the skin. Specifically, it focuses on scars that result from a type of skin cancer surgery called Mohs micrographic surgery. In the study, one side of the surgical wound will be treated with a sunscreen containing zinc, while the other side will not receive any sunscreen. Three months after the surgery, the researchers will compare the scars on both sides to see if the sunscreen made a difference in how they look.
To participate in this trial, you need to be at least 18 years old and scheduled for a skin surgery that will be closed with a straight stitch, like on your face, head, or neck. You also need to be willing to return for a follow-up visit three months later. If you have had a bad reaction to zinc sunscreen in the past, are pregnant, or have certain health conditions, you may not be eligible to join. Participants will help researchers learn more about how sun protection can influence healing and the final appearance of scars.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient is ≥ 18 years of age
- • 2. Patient is able to provide informed consent
- • 3. Patient is scheduled for a cutaneous excisional surgical procedure
- • 4. Cutaneous surgical wound closed via linear repair
- • 5. Surgery performed on sunlight-exposed anatomical regions (head, face, neck, hairless scalp)
- • 6. Patient is willing to return for follow-up visit to clinic
- Exclusion Criteria:
- • 1. Patient is incarcerated
- • 2. Patient is \< 18 years of age
- • 3. Patient is pregnant
- • 4. Patient unwilling to return for 3-month follow-up
- • 5. History of reaction to zinc containing sunscreen
- • 6. History of collagen vascular disease
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials